Serum levels of soluble Fas ligand in patients with silicosis

le Tomokuni, A, Otsuki, T, Isozaki, Y, Kita, S, Ueki, H, Kusaka, M, Kishimoto, T, Ueki, A
Foilsithe 1999

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours

le TOMOKUNI, A, AIKOH, T, MATSUKI, T, ISOZAKI, Y, OTSUKI, T, KITA, S, UEKI, H, KUSAKA, M, KISHIMOTO, T, UEKI, A
Foilsithe 1997

Soluble Fas mRNA is dominantly expressed in cases with silicosis.

le Otsuki, T, Sakaguchi, H, Tomokuni, A, Aikoh, T, Matsuki, T, Kawakami, Y, Kusaka, M, Ueki, H, Kita, S, Ueki, A
Foilsithe 1998

Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individu...

le Ueki, A, Isozaki, Y, Tomokuni, A, Hatayama, T, Ueki, H, Kusaka, M, Shiwa, M, Arikuni, H, Takeshita, T, Morimoto, K
Foilsithe 2002

Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients

le Otsuki, T, Tomokuni, A, Sakaguchi, H, Aikoh, T, Matsuki, T, Isozaki, Y, Hyodoh, F, Ueki, H, Kusaka, M, Kita, S, Ueki, A
Foilsithe 2000

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

le Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M
Foilsithe 2010

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

le Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Foilsithe 2013